{"database": "lobbying", "table": "lobbying_activities", "rows": [[471681, "bc25f627-ef32-446e-9a56-9f9fbc9e2e32", "YY", "MR. MARK SHARPE", 83455, "ANAZAOHEALTH CORPORATION", 2006, "year_end", "PHA", "The Controlled Substance Act - and clarification of rule interpretations regarding the proper dispensing of controlled substances to patients and their physicians.  There is no related bill.  This was a request for clarification regarding the rules pertaining to the Act.", "SENATE", null, null, 0, 0, "2007-02-08T12:08:38-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["471681"], "units": {}, "query_ms": 42.00456093531102, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}